3A70.10

ICD-11 MMS 2026-01

Drug-induced aplastic anaemia

Description

A disease caused by drug intake. This disease is characterised by inability of stem cells to generate new mature cells leading to low levels of red blood cells, white blood cells, platelets. This disease may present with pallor, fatigue, dizziness, increased risk of infection or increased bruising/bleeding.

Index terms

  • Drug-induced aplastic anaemia
  • aplastic anaemia due to drugs
  • medicament-induced aplastic anaemia
Show allHide
  • Aplastic anaemia due to cytostatic therapy

Exclusions from above levels

  • 04 – Diseases of the immune system
  • 05 – Endocrine, nutritional or metabolic diseases
  • 18 – Complications of pregnancy, childbirth or the puerperium
Show allHide
  • 19 – Certain conditions originating in the perinatal period
  • 20 – Congenital malformations, deformations or chromosomal abnormalities
  • 22 – Injury, poisoning or certain other consequences of external causes
  • http://id.who.int/icd/entity/1000704511 – Human immunodeficiency virus disease
  • JB64.1 – Other diseases of the blood or blood-forming organs or certain disorders involving the immune mechanism complicating pregnancy, childbirth or the puerperium

Sibling codes

  • 3A70.11 – Aplastic anaemia due to other external agents
  • 3A70.12 – Idiopathic aplastic anaemia
  • 3A70.1Y – Other specified acquired aplastic anaemias
  • 3A70.1Z – Acquired aplastic anaemias, unspecified

Foundation entity

Drug-induced aplastic anaemia – http://id.who.int/icd/entity/1907114935

Allowed postcoordination axes

Part of: 3A70.1: Acquired aplastic anaemias › 3A70: Aplastic anaemia › 03: Diseases of the blood or blood-forming organs